Converge Technology Solutions Corp.

DB:0ZB Stock Report

Market Cap: €438.9m

Converge Technology Solutions Valuation

Is 0ZB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0ZB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0ZB (€2.26) is trading below our estimate of fair value (€8.74)

Significantly Below Fair Value: 0ZB is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0ZB?

Key metric: As 0ZB is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0ZB. This is calculated by dividing 0ZB's market cap by their current revenue.
What is 0ZB's PS Ratio?
PS Ratio0.3x
SalesCA$2.56b
Market CapCA$648.70m

Price to Sales Ratio vs Peers

How does 0ZB's PS Ratio compare to its peers?

The above table shows the PS ratio for 0ZB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.1x
ADN1 adesso
0.5x11.4%€582.7m
GFT GFT Technologies
0.7x6.1%€583.1m
SHF SNP Schneider-Neureither & Partner
1.6x8.3%€375.8m
YSN secunet Security Networks
1.6x7.9%€632.1m
0ZB Converge Technology Solutions
0.3x1.4%€648.7m

Price-To-Sales vs Peers: 0ZB is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (1.1x).


Price to Sales Ratio vs Industry

How does 0ZB's PS Ratio compare vs other companies in the DE IT Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
ASKN asknet Solutions
0.01x20.1%US$984.32k
No more companies available in this PS range
0ZB 0.3xIndustry Avg. 0.7xNo. of Companies5PS00.61.21.82.43+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0ZB is good value based on its Price-To-Sales Ratio (0.3x) compared to the German IT industry average (0.7x).


Price to Sales Ratio vs Fair Ratio

What is 0ZB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0ZB PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio1x

Price-To-Sales vs Fair Ratio: 0ZB is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0ZB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€2.26
€3.41
+50.8%
16.5%€4.40€2.71n/a11
Nov ’25€1.94
€3.81
+96.5%
25.3%€5.94€2.64n/a11
Oct ’25€3.03
€4.36
+43.8%
18.2%€6.00€3.00n/a11
Sep ’25€3.01
€4.37
+45.1%
18.2%€6.00€3.00n/a11
Aug ’25€2.77
€4.66
+68.1%
14.5%€6.09€3.38n/a11
Jul ’25€2.88
€4.68
+62.6%
14.0%€6.15€3.42n/a12
Jun ’25€3.19
€4.68
+46.5%
14.5%€6.11€3.39n/a11
May ’25€3.71
€4.62
+24.7%
15.5%€6.14€3.41n/a11
Apr ’25€4.00
€4.58
+14.6%
15.7%€6.11€3.39n/a11
Mar ’25€3.43
€4.06
+18.2%
15.6%€4.99€2.93n/a11
Feb ’25€3.10
€4.06
+31.0%
15.6%€4.99€2.93n/a11
Jan ’25€2.84
€3.85
+35.9%
18.0%€4.89€2.70n/a11
Dec ’24€2.66
€3.85
+44.9%
18.0%€4.89€2.70n/a11
Nov ’24€1.86
€3.67
+97.0%
25.3%€4.99€2.07€1.9411
Oct ’24€1.96
€3.61
+84.7%
25.3%€4.91€2.03€3.0311
Sep ’24€1.92
€3.61
+88.6%
25.3%€4.91€2.03€3.0111
Aug ’24€2.13
€4.06
+90.5%
22.2%€5.38€2.08€2.7711
Jul ’24€2.14
€4.06
+90.0%
22.2%€5.38€2.08€2.8811
Jun ’24€2.54
€3.93
+55.0%
22.3%€5.26€2.04€3.1913
May ’24€2.14
€5.03
+134.9%
15.9%€6.69€3.51€3.7113
Apr ’24€2.65
€5.13
+93.6%
15.9%€6.83€3.58€4.0013
Mar ’24€3.24
€5.60
+72.9%
15.7%€6.99€3.67€3.4313
Feb ’24€3.87
€5.96
+54.2%
16.8%€7.19€3.59€3.1013
Jan ’24€3.16
€6.10
+92.8%
16.3%€7.30€3.65€2.8414
Dec ’23€3.45
€6.63
+92.5%
19.1%€10.08€4.68€2.6614
Nov ’23€4.01
€7.58
+89.0%
14.9%€10.40€5.94€1.8614

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies